Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A2B sedation trial in mechanically ventilated ICU patients
ISRCTN18035454Phase 3Completed
- Sponsor
- Academic and Clinical Central Office for Research and Development
- Start
- Sep 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in critical illness comparing Dexmedetomidine, Clonidine and Propofol usual care (3 arms). Primary endpoint: Time to successful extubation post-randomisation. Started Sep 2018; status: completed.
02
Drugs
dexmedetomidineclonidinepropofol
03
Conditions
critical illness
Beyond the preview
Go deeper on ISRCTN18035454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18035454.